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ABSTRACT
Aerobic Exercise Alters Opioid Receptors
Following Chronic Alcohol Exposure
James N. Brundage
Neuroscience Center, Brigham Young University
Master of Science
Opioid receptors have been a target of pharmacological manipulation in alcohol use disorder
(AUD) recovery protocols for many years. Aerobic exercise, a common adjunct in AUD
recovery, is known to modulate opioid receptors (ORs) both during both acute and long term
exposure. The three subtypes of ORs: mu (MOR), delta (DOR), and kappa (KOR) are all
expressed on neurons in the mesocorticolimbic circuitry. Kappa-opioid receptors are expressed
directly on dopamine (DA) neuron terminals in the nucleus accumbens (NAc). Mu and Delta
ORs are expressed on cholinergic interneurons (CINs) and GABA neurons in the NAc. In
alcohol dependent rodents, KORs are hypersensitized. It is theorized that this hypersensitization
contributes to EtOH seeking behavior. In contrast, aerobic exercise desensitizes the KORs.
Given the high degree of pharmacological overlap between opioid receptors, it is also
hypothesized that EtOH and aerobic exercise may have effects on MORs and DORs as well.
Here, it is investigated whether a routine of voluntary aerobic exercise decreases EtOH induced
changes to KOR modulation of dopamine (DA) release in the nucleus accumbens (NAc) along
with possible mechanisms through which this might occur. The responsiveness of MORs and
DORs in EtOH dependence, and how aerobic exercise modulates those effects is also
investigated. Exercise attenuated EtOH induced hypersensitization of KORs in the NAc.
Exercise decreases expression of KORs, which may account for the changes in KOR
sensitization. The MOR agonist DAMGO decreased DA reuptake ex vivo, but not signal
amplitude while DOR agonist DPDPE had no effect on either reuptake or signal amplitude.

Overall, dependent animals that were allowed to exercise, consumed less EtOH in a drinking in
the dark model. These data suggest that exercise is a useful adjunct to AUD recovery protocols,
and that its effects are likely mediated by KORs. The findings related to MORs and DORs
suggest that MORs, but not DORs, may act through acetyl choline receptors to modulate DA
reuptake in the NAc, however much more work is needed to characterize this effect.

Keywords: alcohol, aerobic exercise, opioid receptor, cholinergic interneuron, nucleus
accumbens

ACKNOWLEDGEMENTS
I must first thank my advisor, Dr. Jordan Yorgason, without whose mentorship and
friendship I would not be the researcher I am today. I would also like to thank Dr. Scott
Steffensen who has provided countless learning and growth opportunities for the past four years.
I am extremely grateful to Dr. Kyle Bills, Dr. Daniel Obray and Andrew Payne for their
scientific perspective, personal mentorship and friendship during my time at BYU. This project
would certainly not have been completed without many dedicated undergraduate researchers. I
would especially like to thank Alyssa Stockard, Brandon Richmond, Ben Williams, Charlton
Bassett and Jared Baldridge. Watching their skills and understanding develop has been a
highlight of my graduate studies. Finally, I must thank my ever supportive wife Lindsey, who
has provided inspiration, encouragement and patience throughout this entire process.

TABLE OF CONTENTS

Aerobic Exercise Alters Opioid Receptors Following..................................................................... i
ABSTRACT.................................................................................................................................... ii
ACKNOWLEDGEMENTS ........................................................................................................... iv
LIST OF FIGURES ...................................................................................................................... vii
Aerobic Exercise Alters Opioid Receptors Following Chronic Alcohol Exposure ........................ 1
Alcohol and the Dopamine Hypothesis ..........................................................................1
Common Neuronal Substrates Underlying Alcohol and Opioid Reward and Dependence
.........................................................................................................................................2
Opioid Receptors in the Mesocorticolimbic System ......................................................3
Alcohol and Opioid Receptors ........................................................................................5
Aerobic Exercise, Endogenous Opioids, and AUD ........................................................6
Rationale and Hypotheses ...............................................................................................8
METHODS ..................................................................................................................................... 9
Animals ...........................................................................................................................9
Fast Scan Cyclic Voltammetry .....................................................................................10
Immunohistochemistry .................................................................................................11
Drink-in-the-Dark Procedure ........................................................................................12
Statistical Analysis ........................................................................................................12
RESULTS ..................................................................................................................................... 15
Voluntary Exercise Alters KOR Sensitivity in the NAc...............................................15
v

Voluntary Exercise Changes KOR Density in the NAc and VTA ...............................17
Voluntary Exercise Decreases Seeking Behavior .........................................................17
MOR Activation Elevates Reuptake but Not Amplitude ..............................................18
DOR Activation has Little Direct Impact on DA Release in the NAc in Slice ............19
Regional and Sex Differences in DA Transient Amplitude and Frequency .................20
DISCUSSION ............................................................................................................................... 23
KORs Mediate Exercise Effects on Attenuation of EtOH Induced Hypersensitization23
The Effects of MOR and DOR Activation on DA Release and Reuptake ...................24
Evidence for Regional Heterogeneity in CIN Effects on Striatal DA Release .............26
REFERENCES ............................................................................................................................. 29

vi

LIST OF FIGURES
Figure 1: Overview of Experimental Procedures............................................................................ 9
Figure 2: Voluntary Exercise Alters KOR Sensitivity in the NAc ............................................... 15
Figure 3: Exercise Lowers KOR Density in the NAc and VTA ................................................... 16
Figure 5: Exercise Decreases Drug Seeking Behavior ................................................................. 18
Figure 6: MOR Activation Elevates Reuptake But Not Amplitude ............................................. 19
Figure 7: DOR Activation Doesn't Alter Amplitude or Reuptake ................................................ 20
Figure 8: Dopamine Transients Differ by Region and Sex........................................................... 21

vii

Aerobic Exercise Alters Opioid Receptors Following Chronic Alcohol Exposure
Alcohol and the Dopamine Hypothesis
Alcohol addiction affects the lives of millions of people worldwide. In the US alone, an
estimated 28 million are currently undergoing treatment to recover from the effects of alcohol
abuse disorder (AUD) at a cost of over 249 billion dollars annually (Sacks, Gonzales, Bouchery,
Tomedi, & Brewer, 2015). The disease has dire consequences for those affected, as well as their
families and communities. Despite many advances in treatment options, the one-year relapse rate
remains around 50% (SAMHSA, 2016). Understanding the mechanisms underlying addiction is
vital for preventing relapse and speeding the healing process in recovering addicts.
One common theory on how addiction functions in the brain focuses on changes to dopamine
(DA) release in the mesocorticolimbic system. The nucleus accumbens (NAc) and the ventral
tegmental area (VTA) are two relevant brain regions within this circuit. Dopamine is synthesized
in the cell bodies of DAergic neurons in the VTA whose axons extend into the NAc, where DA
is released (Koob & Volkow, 2010). A variety of neuron subtypes including γ-aminobutyric acid
(GABA)ergic neurons, medium spiny neurons (MSN), glutamatergic neurons and cholinergic
neurons further regulate release (Nolan et al., 2020). Dysregulation of the mescorticolimbic
system is a hallmark of drugs of abuse (Koob & Volkow 2010). One theory proposes that DA
release in the NAc is a scalar index of reward (Wise, 2008). Dopamine release in the striatum
may encode reward timing and/or salience (Berridge & Robinson, 1998; Phillips, Atkinson,
Blackburn, & Blaha, 1993; Schultz, Apicella, Ljungberg, Romo, & Scarnati, 1993). There is
some evidence that reward timing and salience are encoded in different striatal subregions (Cerri,
Saddoris, & Carelli, 2014; Sackett, Saddoris, & Carelli, 2017; Saddoris, Cacciapaglia,
Wightman, & Carelli, 2015). Regardless of how DA release actually translates to motivation and
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behavior, it is clear that DA is a central feature in the pathophysiology of addiction and thus a
relevant area of study for understanding drug abuse along the continuum of reward to
dependence.
Common Neuronal Substrates Underlying Alcohol and Opioid Reward and Dependence
The prevailing theory posits that the addiction cycle is composed of three stages:
‘binge/intoxication’, ‘withdrawal/negative affect’, and ‘preoccupation/anticipation’, with discrete
neuro-circuits mediating each of these stages (Koob & Volkow, 2010). The development of
addiction starts with the ‘binge/intoxication’ stage that is mainly driven by the reinforcing and
rewarding properties of drugs. Both animal and human studies have identified key elements
within the mesolimbic dopamine (DA) system, including the midbrain ventral tegmental area
(VTA) and nucleus accumbens (NAc) of the ventral striatum, that constitute brain substrates
underlying reward. Some maintain that DA neuron activation and release in the mesolimbic DA
system originating in the VTA and projecting to the NAc is literally a scalar index of reward
(Wise, 2008). This system is known to be involved in reward from natural behaviors such as
feeding (Ahn & Phillips, 2002, 2003; Phillips, Ahn, & Howland, 2003), drinking (Agmo,
Federman, Navarro, Padua, & Velazquez, 1993; Agmo, Galvan, & Talamantes, 1995), and others
such as intracranial self-stimulation (Gratton & Wise, 1983; Tzschentke, 2000; Wise, 2002). It
has also been implicated in the habit-forming actions of several addictive drugs (Blackburn,
Phillips, Jakubovic, & Fibiger, 1986; G.F. Koob, 1992; Wise, 1996; Wise, 2004; Wise &
Bozarth, 1987). The dogma is that any drug or behavior that increases mesolimbic DA neuron
activity and release will be reinforcing and potentially addictive (Kalivas, Churchill, & Klitenick,
1993; Kalivas & Volkow, 2005; Nestler, 2001). The prevailing view is that people consume
drugs for their rewarding properties, which are mediated by this system. Addicts continue their
cycle of abuse, in part, as a result of maladapted or depleted DA levels, with its accompanying
2

dysphoria, as well as anxiety and stress mediated by the extended amygdala that accompany
‘withdrawal/negative affect’. Ultimately, continued abuse results in neuroadaptations of cortical
inputs to the mesolimbic system. These adaptations constitute the ‘preoccupation/anticipation’
stage and play an important role in the processing, modulation, and emotional linking (Mitsi &
Zachariou, 2016) that drive subsequent craving and impulse behavior and ultimately dependence
upon the reinforcer. The emerging view is that the dysregulated homeostasis that accompanies
the development of drug addiction may result from experience-dependent neuroadaptations that
hijack normal synaptic transmission in this system (Hyman & Malenka, 2001; Hyman, Malenka,
& Nestler, 2006; Kauer & Malenka, 2007; Nugent & Kauer, 2008). The compulsion to consume
EtOH and opioids stems from their positive reinforcing properties, including their anxiolytic and
euphoric effects, as well as their negative reinforcing properties, including their aversive
withdrawal symptoms that result from abstinence (Koob, Rassnick, Heinrichs, & Weiss, 1994).
Symptoms of dependence accumulate with repeated drug taking and withdrawal (Overstreet,
Knapp, & Breese, 2002).
Opioid Receptors in the Mesocorticolimbic System
Opioid receptors (ORs) are expressed both directly on VTA DA neurons as well as local
striatal GABA and acetyl choline (ACh) neurons, making them a strong potential target for
modulating DA transmission in the dorsal striatum (Karkhanis, Holleran, & Jones, 2017). There
are three traditionally recognized ORs: mu (MOR), delta (DOR), and kappa (KOR). Although
some other types have been proposed, their standing as distinct receptor subtypes is still in
question because they are not pharmacologically sensitive to naloxone. Therefore this manuscript
will focus on the universally recognized three. Each receptor is an inhibitory G-coupled protein
receptor whose activation at many doses leads to subsequent inhibition of firing rate and
neurotransmission via inhibition of adenylate cyclase, reduction of calcium currents, and
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activation of inwardly rectifying potassium channels (Attali, Saya, & Vogel, 1989; Henry,
Grandy, Lester, Davidson, & Chavkin, 1995; Konkoy & Childers, 1989; Prather et al., 1995;
Tallent, Dichter, Bell, & Reisine, 1994). Each receptor has a variety of ligands, many of which
are cross reactive between receptor subtypes. The most common endogenous ligands for these
receptors include dynorphins (DYN), which mainly bind KORs, enkephalins, which mainly bind
MORs and DORs, and endorphins, which mainly bind MORs (Aldrich & McLaughlin, 2009).
Although all ORs are largely inhibitory, their expression on different cell types leads to
differential effects on behavior, especially in reward circuitry. As depicted in Figure 1, KORs are
expressed on DAergic neurons of the VTA that project into the NAc (Mansour, Burke, Pavlic,
Akil, & Watson, 1996; Mansour, Khachaturian, Lewis, Akil, & Watson, 1987; Spanagel, Herz,
& Shippenberg, 1992). These neurons are responsible for the release of DA into the NAc, and
thus KOR activation leads to their inhibition, decreasing accumbal DA (Spanagel et al., 1992). In
contrast, cholinergic interneurons and GABAergic feedback neurons express MORs and DORs
(Hirose et al., 2005; Murakawa et al., 2004; Okutsu et al., 2006; Yoshida et al., 1999).
Mesocorticolimbic GABA neurons are generally involved in the inhibition of VTA DA neurons,
thus activation of MORs and DORs leads to disinhibition of DA neurons and a subsequent
increase in DA in the NAc (Bonci & Williams, 1996; Johnson & North, 1992; Steffensen et al.,
2006). Cholinergic interneurons participate in presynaptic excitation of DA terminals in the NAc
(Nolan et al., 2020). However, there are still many unanswered questions about the relationship
between DA release and cholinergic firing in the NAc. Speaking generally at the behavioral
level, activation of MORs and DORs produce feelings of euphoria (Devine & Wise, 1994), while
KORs produce dysphoria (Shippenberg, Zapata, & Chefer, 2007).
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Alcohol and Opioid Receptors
Direct access to the mesocorticolimbic system is a hallmark of drugs of abuse such as
cocaine, methamphetamine, heroine (Koob & Volkow, 2010). This access enables them to
directly modulate DA release and is thought to explain their potential for addiction. Unlike other
drugs of abuse, the molecular target of EtOH is still unclear, though there is some evidence
suggesting low dose EtOH may bind nicotinic acetylcholine receptors (Unpublished findings
from our lab). One way alcohol it can affect relevant reward circuitry neurons is through
activation of the endogenous opioid system (Gianoulakis, 1993). Interactions between ORs and
EtOH are well-known. In fact, one of the three FDA-approved drugs to treat AUD is the MOR
antagonist naltrexone (e.g., Common brands Revia and Vivitrol), which act to decrease the
craving associated with AUD and opioid use disorder (OUD).
Alcohol triggers the release of endogenous opioids in mesocorticolimbic circuitry (Seizinger,
Bovermann, Maysinger, Hollt, & Herz, 1983). Given that MORs are associated most with
euphoria, it has been proposed that MORs mediate the pleasurable attributes of alcohol. This is
supported by evidence that a common mutation of the CNS derived MOR, A118G
polymorphism, is associated with increased ‘liking’ of alcohol in humans (Beyer, Koch,
Schroder, Schulz, & Hollt, 2004; Bond et al., 1998; Crist & Berrettini, 2014; Ray et al., 2013;
Ray & Hutchison, 2004; van den Wildenberg et al., 2007), although there is some disagreement
(Hendershot, Claus, & Ramchandani, 2016; Sloan et al., 2018). Further support for the role of
ORs in the mesocorticolimbic circuit demonstrates that a blockade of opioid receptors in the
VTA prior to EtOH administration prevents DA release in the NAc (Acquas, Meloni, & Di
Chiara, 1993; Benjamin, Grant, & Pohorecky, 1993; Lee et al., 2005; Tanda & Di Chiara, 1998;
Yoshida et al., 1999). Similarly, MOR knockout mice do not self-administer EtOH (Roberts et
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al., 2000). In contrast, mice that lack DORs show increased EtOH seeking behavior (Roberts et
al., 2001), suggesting that they may play a role in preventing seeking behavior.
Chronic EtOH use changes OR sensitivity in various mesocorticolimbic brain regions. Muopioid receptors are hypersensitized in the NAc of mice when exposed to chronic EtOH
conditions, while they are desensitized in other brain regions such as the substantia nigra pars
reticulata (Cowen, Rezvani, Jarrott, & Lawrence, 1999). However, they also demonstrate a
decreased binding affinity for specific agonist [D-Ala2, N-MePhe4, Gly-ol]-enkephalin
(DAMGO) (Chen & Lawrence, 2000). Kappa opioid receptors are hypersensitized by chronic
EtOH conditions in the NAc, VTA and parts of the amygdala (Melchior & Jones, 2017; Rose et
al., 2016; Sirohi, Bakalkin, & Walker, 2012). Hypersensitization of the KORs is particularly
interesting because it has been proposed that KORs contribute to the “dark side” of addiction
(Karkhanis et al., 2017; Shippenberg et al., 2007; Walker & Koob, 2008). Their
hypersensitization may contribute to increased dysphoria in the anhedonic state (Walker &
Koob, 2008). Indeed, in many animal models, a pharmacological blockade of KORs results in
decreased seeking behavior, though this has yet to be demonstrated in humans (Walker & Koob,
2008). Clearly, ORs play a major role in EtOH’s modulation of mesocorticolimbic circuitry.
The OR system has therapeutic potential. Recovery protocols already utilize opioid based
pharmacological approaches which target MORs, and KOR drugs are currently being tested for
their use in AUD and OUD recovery in humans (Walker & Koob, 2008). However, other nonpharmacological methods can also target ORs.
Aerobic Exercise, Endogenous Opioids, and AUD
A large body of evidence suggests that exercise is well suited to supplement AUD recovery
protocols. Many studies have shown that exercise leads to molecular and psychological changes
6

beneficial to recovery (Lipowski, Szulc, & Bulinski, 2015; Piazza-Gardner & Barry, 2012; D.
Wang, Wang, Wang, Li, & Zhou, 2014). Aerobic exercise, like acute ethanol consumption, has
been shown to increase levels of tyrosine hydroxylase, the rate limiting enzyme in DA synthesis,
in the NAc (Droste, Schweizer, Ulbricht, & Reul, 2006; Greenwood et al., 2011). It has also been
associated with burst activation of DA neurons in the VTA (S. S. Wang, Wei, Liu, & Ren, 2011).
Further, 6-weeks of voluntary wheel running in rats increased D2 auto receptor density in the
NAc (Greenwood et al., 2011); a modification that has been associated with increased risk of
addictive behavior (Martinez et al., 2004; Morgan et al., 2002; Voisey et al., 2012). D2 like
receptors lead to inhibition of DAergic firing, and they are also downregulated in long term
exercise (Greenwood et al., 2011). Along with the molecular data, exercise changes affective
symptoms of addiction. It increases self-efficacy while decreasing depression (Leasure,
Neighbors, Henderson, & Young, 2015; D. Wang et al., 2014).
Despite the myriad of evidence supporting exercise as a potential tool in AUD recovery,
it’s results on both animal and human behavior are mixed (Leasure et al., 2015; D. Wang et al.,
2014). Alcohol preferring mice given access to a running wheel decreased drinking behavior
(Darlington et al., 2016; Ehringer, Hoft, & Zunhammer, 2009; Gallego, Cox, Funk, Foster, &
Ehringer, 2015). Other studies showed that mice in withdrawal consumed less alcohol when
given ad libitum access to a running wheel, however mice that were already accustomed to
running, ran less when given access to EtOH (Ozburn, Harris, & Blednov, 2008). While these
data suggest that aerobic exercise may play a role in hedonic substitution, it also begs the
question of why it only substitutes for EtOH seeking behavior during withdrawal (Ozburn et al.,
2008). Exercise’s role is further complicated by differences in sex, strain of mouse used, and age,

7

suggesting that genetic background plays a significant role in determining how exercise will
affect drinking behavior (Leasure et al., 2015; Ozburn et al., 2008; D. Wang et al., 2014).
Meta-analysis of human studies on aerobic exercise in AUD recovery show that while
exercise decreases EtOH induced depressive symptoms, it does not significantly decrease
drinking behavior (D. Wang et al., 2014). The discrepancy between studies may be due to a lack
of uniformity in the severity of AUD as well as differences in intensity of aerobic exercise,
however this has not been confirmed. As the animal studies suggest, timing of the
implementation of the exercise protocol may play a role in determining its usefulness. Exercise
during withdrawal may act as a substitute for drinking while exercise during other phases of
recovery may only ameliorate affective symptoms. Although it has not been thoroughly
investigated, animal studies suggest that both sex and genetic background may also play a
significant role in determining the efficacy of aerobic exercise in AUD recovery in humans.
Clearly, exercise exhibits molecular effects on addiction in many ways. A better understanding
of exactly how exercise affects specific, reward circuitry relevant molecular systems is needed to
effectively determine when and how exercise should be used in AUD recovery protocols.
Rationale and Hypotheses
This thesis investigates whether and how aerobic exercise modulates the
mesocorticolimbic system via opioid receptors in alcohol dependent animals. Unique to this
study on aerobic exercise and ORs is that it focuses directly on how exercise directly modulates
striatal DA release. By better understanding how non-pharmacological stimuli modulate the
striatal microcircuitry during dependence, we can better use these tools to help addicts. One of
the main advantages of exercise as a treatment adjunct is the relative ease of implementation.
Further, because exercise acts on the same systems as the pharmacological tools used in AUD
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recovery, implementation of exercise protocols may alter normal pharmacological effects. By
understanding how non-pharmacological tools act on opioid receptors, we may be able to
enhance current AUD recovery protocols.

Figure 1: Overview of Experimental Procedures

METHODS
Animals
Male C57BL/6J and DBA/2J mice (Jackson Labs; aged 6-12 weeks) were given ad libitum
access to food and water, and were maintained on a reverse 12:12-h light/dark cycle (lights on at
15:00 h). Mice were randomly assigned to one of three cohorts, ethanol without exercise, ethanol
with exercise and saline with exercise. All mice were injected BID with ethanol (2.5g/kg; 16%
w/v; IP) or an equivalent volume of saline for 14 days. Exercise groups were given ad libitum
access to a running wheel during the 14 day period. Intoxication was visually verified with loss of
consciousness or ataxia which decreased visually with dependence. All protocols and animal care
procedures were in accordance with the National Institutes of Health Guide for the Care and Use
9

of Laboratory Animals and approved by the Brigham Young University Institutional Animal Care
and Use Committee. All efforts were made to minimize animal suffering and number of animals
used in the present study.
Fast Scan Cyclic Voltammetry
Isoflurane (Patterson Veterinary, Devens, MA) anesthetized mice were sacrificed by
decapitation and brains were rapidly removed and transferred into ice-cold, pre-oxygenated (95%
O2/5% CO2) artificial cerebral spinal fluid (aCSF) consisting of (in mM): NaCl (126), KCl (2.5),
NaH2PO4 (1.2), CaCl2 (2.4), MgCl2 (1.2), NaHCO3 (25), glucose (11), L-ascorbic acid (0.4), pH
adjusted to 7.4. Tissue was sectioned into 220 μm-thick coronal slices containing the striatum with
a vibrating tissue slicer (Leica VT1000S, Vashaw Scientific, Norcross, GA). Brain slices were
placed in a submersion recording chamber, and perfused at 1 ml/min at 32 °C with oxygenated
aCSF.
Fast scan cyclic voltammetry (voltammetry) recordings of dopamine signals were
performed and analyzed using Demon Voltammetry and Analysis Software (Demon Voltammetry
and Analysis; Yorgason, Espana, & Jones, 2011). The carbon fiber electrode (7 μm X ~150 μm)
potential was linearly scanned as a triangular waveform from -0.4 to 1.2 V and back to -0.4 V (Ag
vs Ag/Cl) at a scan rate of 400 V/s. Cyclic voltammograms were recorded at the carbon fiber
electrode every 100 msec by means of a potentiostat (Dagan Corporation, Minneapolis, MN).
Dopamine release was evoked every 2 min through a bipolar stimulating electrode. For
input/output experiments examining baseline dopamine signals across increasing current
stimulations, single pulse baseline dopamine signals were collected (4 msec, 350 μA) until signals
were stable for across 3 collections. Baseline single pulse responses were measured followed by
concentration response for U50488 at 0.3 μM and 1 μM, DAMGO at 1 μM and DPDPE 1uM
10

followed by a reversal dose of 1 μM nor-BNI, 1 μM naloxone or 1 μM naltrexone depending on
the receptor being tested; all drugs were bath applied. Each response was gathered from singlepulse stimulations given 2 min apart before introduction of the next drug concentration. In a
separate set of experiments, spontaneous dopamine transients were measured in-between electrical
stimulations. Dopamine transients were observed throughout the dorsal and ventral striatum in
coronal and sagittal slices.
Immunohistochemistry
Mice were anesthetized using isoflurane and underwent transcardial perfusion with 4%
paraformaldehyde (PFA). Once perfused, brains were carefully removed and placed in 4% PFA
for 24 hrs to facilitate continued fixation. After incubation in PFA, brains were placed in a solution
of 30% sucrose in 1X PBS until the density of the brain matched that of the solution and the brains
dropped to the bottom of the vial (~24-48 hrs). Brains were then flash frozen in dry ice and
mounted on a cold microtome stage. Targeting the VTA and NAc, brains were sliced at 30 µm on
the microtome and slices were placed in cryoprotectant (30% ethylene glycol, 30% sucrose,
0.00002% sodium azide, in 0.1 M PB) and kept at -20°C until staining. Slices were washed 3 times
in 1x PBS for 10 minutes on a rotator. They were then blocked with a blocking buffer comprised
of 4% normal goat serum, 0.1% Triton-X 100 and 1x PBS. Slices were then washed another 3
times in 0.2% PBST on a rotator. Primary antibodies were applied and allowed to incubate for 20
hours. Following staining, the slices were washed 3 times in 0.2% PBST and secondary antibodies
were applied. After a 2 hr incubation period they were washed another 3 times with 0.2% PBST
and once with 1x PBS. Antibodies included Mouse anti-tyrosine hydroxylase (Novus, 1:1328),
and Rabbit anti-KOR (LifeSpan, 1:200) as well as secondary Alexa Fluor 405 Donkey Anti-Sheep
antibodies from (1:900) and Alexa Fluor 594 Goat anti-Rabbit (1:500). To mount slides, sections
were placed on microscope slides and dried ~5 min. Once dried, a drop of vectashield (Vector
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Laboratories) was placed on the tissue, and a cover slip was placed on the slide. Slides set
overnight, and then they were kept at 4°C until imaging. An Olympus FluoView FV1000 confocal
microscope was used to image mounted slices. Brain slices were mounted on microscope slides
and imaged under oil immersion at 40X. To ensure consistent readings between samples, a
constant photomultiplier tube voltage and gain were set between all acquired images.
Drink-in-the-Dark Procedure
To observe a behavioral correlate of alcohol dependence and validate our vapor chamber
method, mice were trained and evaluated in a drink-in-the-dark (DID) two-bottle choice alcohol
drinking test. Mice were injected with EtOH as described above. After a withdrawal period of 24
hours, animals were removed from home cages three hours into the dark cycle, and placed
individually in cages with the bedding and food removed. They were given two sipper tubes,
with one containing tap water and the other containing tap water and ethanol (20% v/v). Mice
were allowed to drink from the tubes for 2 hours in the dark, and were then returned to their
home cages. They repeated this test over 4 consecutive days with no injection exposure during
that time.
Statistical Analysis
Dopamine release was analyzed using Demon Voltammetry software and measured at peak
oxidation currents. Dopamine uptake was measured as the time constant (τ) from a single
exponential fit between the peak dopamine current and its return to baseline. Custom software
was written for detecting and analyzing spontaneous dopamine release events. The software
performs a running subtraction on recordings to reduce drift and aliasing noise. Post-subtracted
data is then compared across time against known cyclic voltammograms for dopamine, with a
low threshold r2 value for initial detection (r2>0.3). The location of each putative event
(legitimate and spurious) is captured in the software for subsequent manual verification. The
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program reverts the data back to its non-subtracted form, and performs a new background
subtraction (non-running) at the time point preceding the putative event. The resultant color plot
around that time point, and cyclic voltammogram at the peak current are then examined,
and compared against a known dopamine voltammogram to verify similar oxidation potentials. If
signals are smaller than the limit of detection (calculated by multiplying the median standard
deviation for each file by 3) they are automatically rejected. The events are simultaneously
examined for evidence of a false positive caused by drift and aliasing noise coinciding with the
oxidation potential. Dopamine concentrations were calculated from calibration values (at
1 μM dopamine). Baseline frequency of dopamine transients was measured during a 10
minute period prior to drug application. Group data from experiments where a drug was applied
was measured across a 3 minute period.
Statistics were performed using JMP 15 (JMP®, Version 15. SAS Institute Inc., Cary, NC, 19892019). Statistical significance was determined for groups of 2 variables using a two-tailed
student t-test. Experiments with more than 2 groups, but only one factor were tested for
significance using a one-way analysis of variance (ANOVA) or when data was from multiple
time points from the same experiment a repeated measures ANOVA (RM-ANOVA) was
performed. For experiments that examined multiple factors, and possible interactions, two-way
ANOVA or RM-ANOVAs were used. Tukey’s HSD and Bonferroni correction methods were
used for post-ANOVA analysis.
For brain slice imaging, images were loaded into FIJI software. Images were duplicated
to preserve the original settings while color thresholding and brightness contrast adjustments
were made to determine the location of cells and create ROIs. ROIs were then projected back
onto the unedited images where area and mean intensity were recorded for each channel. This
13

process was performed by three independent raters blinded to the hypothesis. To determine
relative density of KORs, the ratio of mean fluorescence to area was determined.
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RESULTS
Voluntary Exercise Alters KOR Sensitivity in the NAc
It was hypothesized that a routine of voluntary exercise would attenuate EtOH induced
hypersensitization of KORs. Kappa opioid receptor sensitivity was measured as reactivity of
KORs to the KOR agonist U50,488 and antagonist nor-BNI on DA release and reuptake in the
NAc. Mice were randomly assigned to one of three cohorts, EtOH without exercise, EtOH with
exercise, and saline with exercise. All mice were injected twice/day (BID) with EtOH (2.5g/kg;
16% w/v; IP) or an equivalent volume of saline for 14 days. Exercise groups were given ad
libitum access to a running wheel during the 14 day period.

Figure 2: Voluntary Exercise Alters KOR Sensitivity in the NAc: Example traces of KOR sensitivity for the EtOH/No
Exercise group (A), EtOH/Exercise groups (B) and the Saline/Exercise group (C). Quantification of group effects in terms of
signal amplitude (D) and reuptake (E) with an n = 6 slices per group.
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Chronic EtOH animals who did not have access to a running wheel showed a 21% ± 5%
(p-value = 0.0329) drop in signal amplitude from baseline following administration of 0.3 μM
U50,488 and a 36% ± 6% (p-value = 0.0002) drop from baseline when the dose was increased to
1 μMU50,488. Antagonist nor-BNI did not significantly increase peak height (p-value = 0.9302).
In contrast, chronic EtOH animals that were allowed access to a running wheel did not
demonstrate a statistically significant change from baseline following any of the drugs
administered (F3,11 = 0.8299; p-value = 0.5047). The saline and exercise group also showed no
change from baseline (F3,12 = 1.39; p-value = 0.2926).

Reuptake was not altered for mice in the EtOH without exercise group (F3,24 =
Figure 3: Exercise Lowers KOR Density in the NAc and VTA: Example images of KOR expression following EtOH and
exercise procedures or controls in the NAc (A-C) and VTA (D-F). Quantification of mean fluorescence intensity of KOR
fluorescence in the NAc (G) and VTA (H), n = 6 animals per group.

1.65; p-value = 0.2049), the EtOH with exercise group (F3,11 = 0.2029; p-value = 0.8922) or the
saline with exercise group (F3,12 = 0.8804; p-value = 0.2204). These results indicate that exercise
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attenuates and possible prevents EtOH induced KOR hypersensitization and that KOR signaling
does not significantly affect reuptake. The lack of responsiveness in the saline group may be the
result of KOR desensitization due to exercise alone.
Voluntary Exercise Changes KOR Density in the NAc and VTA
After observing changes in EtOH induced KOR sensitization from voluntary exercise via
FSCV, it was hypothesized changes to KOR density were responsible for the effects of chronic
EtOH and the attenuation of those effects by exercise. Changes to KOR density in the NAc and
VTA were investigated with immunohistochemistry (IHC).
The mean fluorescent intensity (MFI) in the NAc of the EtOH group without exercise
was 7.08 ± 0.085, while MFI in the EtOH with exercise group and the saline with exercise group
were 3.25 ± 0.125 and 3.77 ± 0.11 respectively. In the VTA, MFI followed a similar pattern with
MFIs of 5.46 ± 0.15, 3.48 ± 0.16 and 3.84 ± 0.14 for the EtOH no exercise, EtOH exercise and
saline exercise groups respectively. All exercise groups were significantly lower than the nonexercise groups in the same region at the same level of significance (p-value < 0.0001). These
data indicate that changes to KOR density in both the NAc and VTA contribute to changes in
KOR sensitivity in the NAc following EtOH and exercise.
Voluntary Exercise Decreases Seeking Behavior
It was also hypothesized that changes to KOR sensitivity and density are related to
changes in EtOH seeking behavior. Significant differences were noted between the average of all
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Figure 4: Exercise Decreases Drug Seeking Behavior: Daily break down of EtOH consumption(A) and quantification of average
EtOH consumed (B) n = 6 animals per group.

groups for all days (F2,43 = 11.2596, p=0.0001). The EtOH no exercise group drank on average
1.05g ± 0.063 in the drink-in-the-dark (DID) procedure while the ethanol with exercise group
drank 0.747g ± 0.098). Interestingly, the saline with exercise group drank more than either with
an average consumption of 1.37g ± 0.089.
These data demonstrate that voluntary exercise decreases EtOH consumption in
dependent animals in the DID paradigm. Surprisingly, the group that was non-dependent and
exercised showed increased drinking behavior compared to both groups.
MOR Activation Elevates Reuptake but Not Amplitude
Mu opioid receptors are expressed on cholinergic interneurons and local GABA neurons
which alter DA release in the accumbens. Given the high degree of pharmacological homology
between ORs, it was hypothesized that MORs may also be changing in response to EtOH,
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aerobic exercise, or both. In the slice
preparation, the effects of DAMGO
administration was previously unclear. Although
other MOR agonists decrease basal CIN firing
rate, they also increase burst firing in the
presence of glutamate (Chieng & Bekkers,
2001). Changes to MOR sensitivity in terms of
signal amplitude and reuptake were also
investigated.
DAMGO (1 μM) had no effect on signal
amplitude in any of the treatment conditions
(F5,59=0.5775; p-value = 0.7170). However,
DAMGO elevated tau by 52% ± 18% (95%

Figure 5: MOR Activation Elevates Reuptake But Not Amplitude:
Representative trace showing response of DA release to DAMGO
1uM (A). Quantification of DAMGO 1uM effects on signal
amplitude (B) and reuptake (C) with an n = 6 slices in each group.

CI 11%-94%; p-value = 0.0055) while the tau
value following naloxone administration was not significantly different than baseline (p-value =
0.5959), indicating that naloxone restored tau to baseline levels. Neither EtOH nor exercise
altered these effects, suggesting unexplored MOR effects on DA uptake are unaffected by
chronic EtOH use or a routine of aerobic exercise.
DOR Activation has Little Direct Impact on DA Release in the NAc in Slice
Along with the MORs, DORs are also expressed on CINs and local GABA neurons, and
it was hypothesized that they may also contribute to the effects of EtOH and exercise on DA
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release in the NAc. Changes to DOR
sensitivity in terms of signal amplitude and
reuptake were also investigated.
Unlike MORs, DOR agonists did not
significantly elevate signal amplitude
(F3,8=0.8531; p-value = 0.5032) or tau (F3,8
= 0.4859; p-value = 0.7015). Delta opioid
receptor antagonists also failed to alter
signal amplitude (F3,8 = 0.6643; p-value =
0.5970) or tau (F3,8 = 0.4991; p-value =
0.6932). These data indicate that DORs have
little effect on DA release in the NAc when
Figure 6: DOR Activation Doesn't Alter Amplitude or Reuptake:
Representative trace showing response of DA release to DPDPE
1uM (A). Quantification of DPDPE 1uM effects on signal
amplitude (B) and reuptake (C) with an n = 6 slices in each group
except EtOH Exercise, which has an n = 2 slices.

activated independently.

Regional and Sex Differences in DA Transient Amplitude and Frequency
Cholinergic interneuron effects on DA release can be measured by investigating DA
spontaneous DA release events known as dopamine transients. As the findings with MORs and
DORs deviated from current literature, it was hypothesized that regional differences in
cholinergic synapses may be responsible. It was also hypothesized that sex may also contribute
to CIN effects in slice. In order to investigate whether CIN effects on DA release varied by
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Figure 7: Dopamine Transients Differ by Region and Sex: Representative examples of spontaneous DA release events in a
current/time plot (A) and a color plot (B). Quantification of DA transient amplitude (C) with regional comparisons by sex (D-E)
and frequency (F) an overall sex comparison (G) with an n = 5-8 slices in each region and sex.

striatal subregion or by sex, transient DA release was recorded by fast scan cyclic voltammetry
(FSCV).
For males, DA transient amplitude was 112.96% ± 9.87% larger in the DS than the NAc
core (95% CI 57.95%, 187.14% ; Bonferroni adjusted p-value =
0.0009) and 44.43% ± 12.9% larger in the NAc shell and the NAc core (95% CI 18.31%, 62.2%;
Bonferroni adjusted p-value = 0.0009). There is no significant difference in the amplitude of
males between the DS and the NAc shell (95% CI 15.21% smaller, 65.15% larger; Bonferroni
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adjusted p-value = 0.9891). In females there was no significant difference in transient amplitude
between the DS and NAc core (95% CI 48.26%, 7.81% ; Bonferroni adjusted p-value = 0.1098),
the DS and NAc shell (95% CI 63.72%, 160.89% ; Bonferroni adjusted p-value = 8.3646) or
the NAc core and the NAc shell (95% CI 51.55%, 250.2% ; Bonferroni adjusted p-value =
3.5712). These results indicate that in males, amplitude varies by region similar to previous
studies from DS to NAc core. However, in females there are no regional differences in DA
transient amplitude.
Frequency of DA transients was also investigated. For the measurement of amplitude, the
effects of sex were dependent on region, and thus the model was fit with an interaction term
between the two. However, for frequency, the interaction term between sex and region is not
significant (p-value = 0.84). This is unsurprising given that the same pattern of regional
frequency appears in both males and females. For this reason, the model for frequency was fit
without the interaction term.
Frequency in the DS is greater than in the NAc shell by 18% ± 4% (95% CI 9%, 27%; pvalue < 0.0001) greater in the NAc core than in the NAc shell by a factor of 14% ± 4% (95% CI
5%, 24%; p-value = 0.0014). While the difference between DS and NAc core is not significant
(p-value = 0.4389) it does follow a dorsal ventral gradient. The median male frequency is larger
than in females by a factor of 12% ± 3% (95% CI 5%, 19%; p-value = 0.0006). Thus, there are
clear regional differences in DA transient frequency in both males and females. The pattern of
regional differences is the same for both sexes, but females have lower frequency than males
across all regions.
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DISCUSSION
KORs Mediate Exercise Effects on Attenuation of EtOH Induced Hypersensitization
Figures 1, 2 and 3 demonstrate that aerobic exercise modulates the KOR system. Animals
exposed to EtOH alone were hypersensitive to U50,488, while animals that underwent a routine
of aerobic exercise were not (Fig. 1A-D). Although there was no statistically significant change
from baseline in EtOH exercise mice after U50,488 administration, the direction of the amplitude
indicates that those slices may only be slightly responsive to that dose (Fig. 1D). Reuptake was
unaffected by KOR drugs (Fig. 1E). Exercised animals also demonstrated lower levels of KOR
density in both the NAc and VTA (Fig. 2). It is therefore proposed that aerobic exercise
ameliorates the hypersensitization of KORs by downregulating receptor density in those regions.
Exercise is a common adjunct to AUD recovery protocols with mixed success though no
mechanism has explained its action on reward circuitry. While aerobic exercise has countless
effects on the body, these data suggest that changes to the DYN/KOR system represent at least
one pathway through which exercise directly modulates reward circuitry to affect EtOH seeking
behavior. In line with this hypothesis, exercised animals drank significantly less than animals
who were not allowed to exercise (Fig. 3).
These data also better inform the use of opioids in AUD disorder treatment.
Pharmacological approaches to AUD recovery protocols include naltrexone, a partial MOR,
DOR and KOR antagonist as well as more specific KOR antagonists. These data support the
theory that KOR antagonism may help reduce seeking behavior. Because aerobic exercise acts to
prevent EtOH induced hypersensitization, it may reduce the dose of KOR antagonist needed to
effectively reduce seeking behavior, or enhance KOR antagonist results. Future studies of
exercise on the DYN/KOR system should investigate whether aerobic exercise enhances the
therapeutic effects of KOR antagonists.
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While there is consistent evidence that KORs are hypersensitized in dependent animals,
previous work has not characterized the mechanism of hypersensitization. The sensitization may
be the result of changes to KOR affinity for DYN or through an increase in KORs at the plasma
membrane. There is evidence that both sensitization and density change during this process
(Arida et al., 2015). It is unclear why chronic EtOH causes these changes.
Ethanol elicits the release of DYN (Karkhanis et al., 2017). This chronic release may
trigger changes in receptor density via changes to the b-arrestin family of downstream effectors.
These changes may also be caused by a separate allosteric modulator of KORs. Generally
speaking however, repeated stimulation of a receptor results in desensitization via an increase in
receptor turnover at the plasma membrane. This is the opposite of the effect of repeated EtOH
exposure demonstrated in Figure 1. While acute EtOH has been shown to increase DYN levels,
no studies have investigated whether this effect persists throughout dependence. It is possible
that EtOH stimulated DYN release decreases throughout the acquisition process, leading to KOR
sensitization. Dynorphin release also occurs following acute stress (Karkhanis et al., 2017), and
chronic stress results in KOR hypersensitization. It is possible that KOR sensitization due to
stress and EtOH are occurring by the same mechanism.
The Effects of MOR and DOR Activation on DA Release and Reuptake
In addition to the effects on the KORs, exercise and EtOH effects on the MORs were also
investigated. For rodents in vivo, MOR agonists clearly elevate DA release in the NAc; however,
ex vivo effects of MOR and DOR agonism are less clear than those of the KORs in the literature.
Some studies demonstrate that MOR agonists decrease signal amplitude (Britt & McGehee,
2008) , though this was only successful in the dorsal region of the NAc shell. Other striatal
regions showed less consistent effects of MOR agonists. Isolated from VTA inputs, MORs are
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expressed on CINs and striatal GABA neurons; and it is theorized that MOR effects ex vivo can
be largely attributed to the presynaptic effects of CINs on DA terminals via muscarinic and
nicotinic acetylcholine receptors.
We found that DAMGO (1 μM) had no effect on signal amplitude, but clearly slowed
reuptake (Fig. 4A-C). Changes to reuptake were reversed to baseline by naloxone administration
(Fig. 4C). The lack of effect on signal amplitude is not surprising given that recordings were
performed primarily in the NAc core rather than the dorsal NAc shell. Previous literature did not
report on reuptake in any regions, and we are therefore unsure whether our findings match the
previous literature. Evidence that the muscarinic acetylcholine agonist oxotremorine decreases
reuptake and is reversed by antagonist scopolamine supports the idea that muscarinic
acetylcholine receptors modulate DAT function (Shin, Adrover, & Alvarez, 2017). In theory,
elevated ACh transmission at muscarinic varicosities would also decrease reuptake.
Unfortunately, there is still much to be discovered about the relationship between MOR
agonists and ACh transmission. There is evidence that MOR and DOR agonists decrease ACh
transmission in the NAc (Kiguchi et al., 2016). Such evidence fits with the activity of MORs as a
Gi-couled receptor. In contrast, there is also evidence that while MOR agonists decrease CIN
firing rate, they also increase burst firing (Hopf et al., 2007), especially in response to local
glutamate (unpublished findings). The two possible effects of DAMGO on CINs are further
complicated by the need to distinguish firing rate data collected at the cell body, and actual
effects on transmission at varicosities. Because there is no data regarding the synaptic
distribution of MORs, it is difficult to know the exact effects of MORs on presynaptic ACh
release on DA terminals and whether they differ from effects at the cell body. Our findings
indicate that DAMGO administration may increase ACh release, likely at muscarinic ACh
25

receptors, resulting in decreased DA reuptake. Further work needs to be done to determine
whether DAMGO actually increases ACh in some instances and regions, and whether these
effects are sufficient to modulate DAT activity.
In conjunction with the MORs, DORs are also expressed on CINs and local GABA
neurons in the NAc. Our results indicate that DOR agonist DPDPE had no clear effect on DA
amplitude or reuptake in the NAc (Fig. 3). This finding is surprising, given that many of the
same studies indicating MOR responses also demonstrated similar findings for DORs. However,
our investigations may be in different subregions of the striatum rather than targeted to the dorsal
NAc shell. Striatal regional differences have been for a variety of different substrates and
functions. These data highlight the importance of regional specificity in determining the effects
of various receptors, especially those expressed on CINs. Recent work in the lab has
demonstrated regional differences in spontaneous DA release shown here, a phenomenon driven
by CINs in slice (Yorgason, Zeppenfeld, & Williams, 2017).
Evidence for Regional Heterogeneity in CIN Effects on Striatal DA Release
Transients were investigated in terms of signal amplitude and frequency. Frequency is a
measure of the number of transient events detected and may indicate changes in likelihood of
spontaneous release or the likelihood of spontaneous event detection. Given that DA neuron
terminals are severed from their cell bodies in the VTA and our previous findings (Yorgason et
al., 2017), it is believed that CINs underlie DA transient activity via presynaptic excitation.
In males, it was found that DA transient amplitude was highest in the DS, followed by
the NAc shell and finally the NAc core (Fig. 6D). While a difference was detected between the
DS and NAc core, no difference was detected between the DS and NAc shell (Fig. 6D). While
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this is in slight contrast to previous findings that amplitude varies on a dorsal to ventral gradient,
it is possible that the slight variability is due to separate factors affecting DA release amplitude.
Signal amplitude is a measure of the amount of DA released and changes to amplitude
may reflect differences in the amount of DA stored per vesicle, the number of vesicles released
in a spontaneous event or an increase in the number of DA synapses involved in release. During
evoked DA release, a consistent depolarizing stimulus is given in the exact same spot for the
course of the experiment. This means that the same number of terminals are likely involved in
each signal, making the amplitude value simpler to interpret. Dopamine transients are likely
affected by many of the same factors as evoked amplitude, but are also subject to increasing
variability due to a potential host of other factors including uneven CIN connectivity and
different numbers of terminals activating at different times. Despite more competing
explanations, the DS still has the highest DA baseline and it is significantly larger than in
the NAc core, the next most ventral region (Fig. 6F). The NAc shell amplitude is the only one
that deviates from previous literature. This indicates the need for further exploration of factors
that may separate the NAc shell from the other two regions.
Surprisingly, no regional differences in transient amplitude were found in females (Fig.
F). To the best of the author’s knowledge, no regional differences in FSCV DA release for
females, evoked or spontaneous, have been previously investigated. These sex differences may
be explained by a large host of substrates and processes including KORs, D2 autoreceptors, nitric
oxide release and Ca+2 channel variability (Calipari et al., 2017), and further work is needed to
further elucidate the mechanisms behind sex differences. The lack of regional differences in
female mice contributes to growing evidence that there are important differences between the
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striatal circuitry of males and females. Further work should be done investigating mechanisms
behind differences in regional distribution of DA release.
DA transient frequency also varied by region with the highest frequency in the DS
and NAc core and a lowest frequency in the NAc shell (Fig. 6F). The same pattern was seen for
males and females, though males had higher frequency in all brain regions (Fig. 6G). This
demonstrates that likelihood of transient detection is highest in the DS and NAc core and lower
in the NAc shell which likely reflects differential qualities of CIN synapses in different striatal
subregions. Successful connectivity is related to either the number of synapses or the subunit
makeup of nAChRs. One group has demonstrated striatal regional differences in nAChR subunit
makeup (Threlfell et al., 2010), suggesting that nAChR subunit variance is a strong candidate for
explaining regional differences in DA, though further work is needed to confirm. Investigation of
DA transient reuptake is also required to rule out the possibility that differences in vesicle
reuptake or packaging are responsible for these effects.
There remains a lot of work to characterize the relationship between MOR and DOR
activation on CINs and their effects on striatal DA release. Previous work on MOR and DOR
release has focused on only a small region where opioid effects were easily detectable in slice.
Our studies indicate that it will be important moving forward to investigate these effects in
various striatal subregions and both sexes in order to understand DA release in a more nuanced
way.
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